NFKB1 and breast carcinoma: All of these reports prompted us to explore whether the DS variants of a known structure that had previously been shown to quickly induce necroptosis and/or significantly reduce the viability of luminal breast cancer cells could influence the activity of NFκB, cause a rapid redox imbalance as well change the actin cytoskeleton arrangement in those cells.